354 related articles for article (PubMed ID: 34321474)
21. SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms.
O'Donoghue SI; Schafferhans A; Sikta N; Stolte C; Kaur S; Ho BK; Anderson S; Procter JB; Dallago C; Bordin N; Adcock M; Rost B
Mol Syst Biol; 2021 Sep; 17(9):e10079. PubMed ID: 34519429
[TBL] [Abstract][Full Text] [Related]
22. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.
Hudák A; Letoha A; Szilák L; Letoha T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069441
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
24. Virus-specific editing identification approach reveals the landscape of A-to-I editing and its impacts on SARS-CoV-2 characteristics and evolution.
Song Y; He X; Yang W; Wu Y; Cui J; Tang T; Zhang R
Nucleic Acids Res; 2022 Mar; 50(5):2509-2521. PubMed ID: 35234938
[TBL] [Abstract][Full Text] [Related]
25. Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.
Bell BN; Powell AE; Rodriguez C; Cochran JR; Kim PS
Protein Sci; 2021 Apr; 30(4):716-727. PubMed ID: 33586288
[TBL] [Abstract][Full Text] [Related]
26. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
27. Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis.
Kemenesi G; Tóth GE; Bajusz D; Keserű GM; Terhes G; Burián K; Zeghbib S; Somogyi BA; Jakab F
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572725
[TBL] [Abstract][Full Text] [Related]
28. Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain.
Antonopoulos A; Broome S; Sharov V; Ziegenfuss C; Easton RL; Panico M; Dell A; Morris HR; Haslam SM
Glycobiology; 2021 Apr; 31(3):181-187. PubMed ID: 32886791
[TBL] [Abstract][Full Text] [Related]
29. Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides.
Maas MN; Hintzen JCJ; Löffler PMG; Mecinović J
Chem Commun (Camb); 2021 Apr; 57(26):3283-3286. PubMed ID: 33651072
[TBL] [Abstract][Full Text] [Related]
30. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
Askari N; Hadizadeh M; Rashidifar M
Infect Genet Evol; 2022 Jan; 97():105195. PubMed ID: 34954105
[TBL] [Abstract][Full Text] [Related]
31. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
32. Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.
Xie M; Xuan B; Shan J; Pan D; Sun Y; Shan Z; Zhang J; Yu D; Li B; Qian Z
J Virol; 2015 Mar; 89(6):3049-61. PubMed ID: 25552713
[TBL] [Abstract][Full Text] [Related]
33. Structure and function analysis of a potent human neutralizing antibody CA521
Song D; Wang W; Dong C; Ning Z; Liu X; Liu C; Du G; Sha C; Wang K; Lu J; Sun B; Zhao Y; Wang Q; Xu H; Li Y; Shen Z; Jiao J; Wang R; Tian J; Liu W; Wang L; Deng YQ; Dou C
Commun Biol; 2021 Apr; 4(1):500. PubMed ID: 33893388
[TBL] [Abstract][Full Text] [Related]
34. Computational Prediction of Mutational Effects on SARS-CoV-2 Binding by Relative Free Energy Calculations.
Zou J; Yin J; Fang L; Yang M; Wang T; Wu W; Bellucci MA; Zhang P
J Chem Inf Model; 2020 Dec; 60(12):5794-5802. PubMed ID: 32786709
[TBL] [Abstract][Full Text] [Related]
35. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
[TBL] [Abstract][Full Text] [Related]
36. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
37. Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features.
Hassan SS; Ghosh S; Attrish D; Choudhury PP; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Uversky VN; Seyran M; Pizzol D; Adadi P; Soares A; El-Aziz TMA; Kandimalla R; Tambuwala MM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Á; Chauhan G; Palu G; Brufsky AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322198
[TBL] [Abstract][Full Text] [Related]
38. Interferon-induced transmembrane proteins inhibit cell fusion mediated by trophoblast syncytins.
Zani A; Zhang L; McMichael TM; Kenney AD; Chemudupati M; Kwiek JJ; Liu SL; Yount JS
J Biol Chem; 2019 Dec; 294(52):19844-19851. PubMed ID: 31735710
[TBL] [Abstract][Full Text] [Related]
39. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M
Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076
[TBL] [Abstract][Full Text] [Related]
40. Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein.
Heinzelman P; Romero PA
PLoS One; 2021; 16(5):e0251585. PubMed ID: 33979391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
